# Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes Mellitus

> **NCT01472614** · PHASE3 · COMPLETED · sponsor: **Dexa Medica Group** · enrollment: 54 (actual)

## Conditions studied

- Type-2 Diabetes Mellitus

## Interventions

- **DRUG:** DLBS3233

## Key facts

- **NCT ID:** NCT01472614
- **Lead sponsor:** Dexa Medica Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2013-01
- **Final completion:** 2013-04
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2013-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01472614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01472614, "Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01472614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*